ATTO-3712

N/A

Report date: 2025/04/25 11:05:26
First In Class

Base Information

Drug NameATTO-3712
Drug Alias NameATTO-3712
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionInterleukin-31 inhibitorsInterleukin-13 inhibitors
TargetsInterleukin-31Interleukin-13
Therapy Area/IndicationsPruritusDermatitis, Atopic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAttovia Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAttovia Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsPruritusDermatitis, Atopic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A